In hemodialysis, a certain degree of bacterial contamination on the di
alysate side is a regular finding. Concern has been growing that this
contamination may lead to a chronic inflammatory response in the patie
nt. Ultrafiltration of dialysate can be used to reduce bacterial conte
nt and levels of cytokine-inducing substances upstream of the patient'
s dialyzer. The aim of this study was to test in vitro the rejection c
apacity of a polysulfone hollow-fiber ultrafilter (ETF 609, NISSHO Co.
, Osaka, Japan) challenged with bacterial filtrates derived from Pseud
omonas aeruginosa PA103. Results showed a reduction of interleukin-1 b
eta-inducing activity (measured on peripheral blood mononuclear cells)
from 5,035 +/- 394 pg/ml prefilter to nondetectable levels postfilter
and endotoxin levels (limulus amebocyte lysate assay) of 4,167 +/- 1,
079 versus 12 +/- 2 pg/ml, respectively. In conclusion, ultrafiltratio
n of dialysate with the polysulfone ultrafilter ETF 609 leads to a pot
ent reduction of cytokine-inducing activity.